Related Experiment Videos
Improving prognosis for malignant melanoma in Britain
The British Journal of Surgery
|December 1, 1984
Summary
Malignant melanoma patients in Cardiff show a 73.3% 5-year survival rate, exceeding previous British data and common internal cancers. Improved diagnosis and early detection of superficial spreading melanoma contribute to this optimistic prognosis.
Area of Science:
- Oncology
- Dermatology
- Epidemiology
Background:
- Malignant melanoma survival rates vary significantly.
- Previous British series reported lower survival rates compared to Australian data.
- Common internal malignancies generally have poorer prognoses.
Purpose of the Study:
- To analyze the 5-year survival rate of malignant melanoma patients in Cardiff.
- To compare Cardiff's survival rates with previous British and Australian series.
- To identify factors contributing to the observed survival rates.
Main Methods:
- Analysis of a consecutive series of 225 malignant melanoma patients.
- Calculation of 5-year cumulative survival rate.
- Comparison with historical data from British and Australian studies.
Main Results:
- A 5-year cumulative survival rate of 73.3% was observed in Cardiff.
- This rate is superior to previous British series and comparable to Australian rates.
- The survival rate significantly exceeds that of common internal malignancies.
Conclusions:
- The improving prognosis for malignant melanoma may be linked to more accurate diagnoses.
- An increasing incidence of superficial spreading melanoma, amenable to early detection, likely contributes to better outcomes.
- These findings support optimism for future public and professional education initiatives.